Company Overview
- Headquarters
- 65 Grove Street, Watertown MA
- Website
- selectabio.com
- Phone
- (617) 923-1400
- Employees
- 22
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:SEL
Financials & Stats
Revenue
$50B
Who is Selecta Biosciences
Selecta Biosciences, a publicly traded biotechnology company, is headquartered in Watertown, Massachusetts. The company currently employs 22 individuals. Selecta Biosciences focuses on developing RNA cell therapy to treat autoimmune diseases. Their pipeline includes Descartes-08, a clinical-stage product candidate currently being evaluated in patients with myasthenia gravis and other autoimmune diseases. Selecta Biosciences was formed through the November 2023 merger with Cartesian Therapeutics. This merger resulted in a combined company focused on advancing Cartesian’s existing pipeline of treatments. For more information about Selecta Biosciences and their latest updates, please visit their website at www.cartesiantherapeutics.com/ or follow them on LinkedIn @Cartesian-Therapeutics.
Company Leadership
Selecta Biosciences Industry Tags
Companies Similar to Selecta Biosciences
Analyze industry trends and opportunities by examining competitors and companies comparable to Selecta Biosciences, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |